拉塔诺普罗斯:第一个氧化捐赠的抗白内障药物
Ghazaleh Soltani1, Wesam Shamseldin Shalaby1,2, Reza Razeghinejad1
1Glaucoma Service, Wills Eye Hospital, Philadelphia, PA, USA.
Medical gas research
|January 20, 2025
概括
拉塔诺普罗斯布诺德通过双流出通道机制有效降低青光眼患者的眼内压力. 这种氧化捐赠的前列腺素类似物显示出对维护视力有希望的有效性和安全性.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 玻璃眼是全球不可逆转的视力丧失的主要原因,其特点是视觉神经病变和视野缺陷.
- 升高的眼内压力 (IOP) 是一种主要的风险因素,也是青光眼治疗的目标.
- 医疗治疗是开角玻璃眼和眼睛高血压的初始方法.
研究的目的:
- 审查拉坦普洛斯0.024%眼科溶液的作用机制,疗效,安全性和耐受性.
- 为了评估拉坦普洛斯布诺德对眼睛血流和视网膜质细胞存活率的影响.
主要方法:
- 临床试验和实践研究对latanoprostene bunod. 的综述.
- 分析其双重机制,以增强通过椎网和脑膜膜通路的水性幽默外流.
- 检查其氧化捐赠元件的作用.
主要成果:
- 拉塔诺普罗斯布诺德显示出显著的内脏压力降低功效.
- 该药在临床和现实环境中表现出良好的安全性和耐受性.
- 氧化成分显示出改善眼球血流和保护视网膜质细胞的潜力.
结论:
- 拉塔诺普罗斯布诺德是一种有效的治疗选择,可以降低玻璃眼的眼内压力.
- 它的双重机制和潜在的眼球血流益处有助于其治疗价值.
- 未来的发展可能包括固定组合和持续释放配方,以加强对青光眼的治疗.
相关概念视频
Open Angle Glaucoma: Treatment
390
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
390
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
147
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147
Antihypertensive Drugs: Vasodilators
472
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
472
Angle Closure Glaucoma: Treatment
433
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
433
Antianginal Drugs: Nitrates and β-Blockers
512
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
512
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
132
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
132


